MedPath

Clinical Value of CA 19-9 with Reference to the Lewis Blood Group Status for Prediction of Benign and Malignant Obstructive Jaundice

Not Applicable
Conditions
Obstructive jaundice
CA 19&#45
9
Lewis blood group
Registration Number
TCTR20160927002
Lead Sponsor
The Thailand Research Fund (TRF)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
129
Inclusion Criteria

- Obstructive jaundice patients whose common bile duct dilates 8 mm or more and has a conjugated hyperbilirubinemia who will undergo ERCP

Exclusion Criteria

- History of biliary drainage
- Cirrhosis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath